Pharmacokinetic and pharmacodynamic assessment of oral nicotinamide in the NEAT clinical trial for early Alzheimer’s disease
Authors
- Gregory J. Brewer (ORCID: https://orcid.org/0000-0002-8535-1832)
- Robert A. Rissman (ORCID: https://orcid.org/0000-0001-9245-8278)
- Howard Feldman (ORCID: https://orcid.org/0000-0002-9258-4538)
- Felix Grün (ORCID: https://orcid.org/0000-0002-1891-7285)
- Joshua D. Grill (ORCID: https://orcid.org/0000-0002-4215-7589)
- Gabriel L Ketron
Institutions
- University of California, Irvine (US)
- University of California San Diego (US)
- Alzheimer’s Disease Neuroimaging Initiative (US)
Publication Details
- Journal
- Alzheimer s Research & Therapy
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1186/s13195-025-01693-y
- Citations
- 8
- Primary Topic
- Cholinesterase and Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 11.16